Literature DB >> 10747283

Glucose-6-phosphate dehydrogenase deficiency in northern Vietnam.

P Verlé1, D H Nhan, T T Tinh, T T Uyen, N D Thuong, A Kongs, P Stuyft, M Coosemans.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency was evaluated in 1676 schoolboys in northern Vietnam. The trait was nearly absent in boys of the Kinh (0.5%) and the Mong (0.7%) ethnic groups that traditionally have lived outside malaria transmission areas. Prevalences among ethnic groups living in the foothills, the breeding area of the main malaria vector Anopheles minimus, ranged from 9.7% to 31%. These findings support the hypothesis of a selective advantage of the trait in Plasmodium falciparum-endemic areas.

Entities:  

Mesh:

Year:  2000        PMID: 10747283     DOI: 10.1046/j.1365-3156.2000.00542.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  7 in total

Review 1.  Piperaquine: a resurgent antimalarial drug.

Authors:  Timothy M E Davis; Te-Yu Hung; Ing-Kye Sim; Harin A Karunajeewa; Kenneth F Ilett
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Molecular Characterization and Genotype-Phenotype Correlation of G6PD Mutations in Five Ethnicities of Northern Vietnam.

Authors:  Thi Thao Ngo; Thinh Huy Tran; Thanh Dat Ta; Thi Phuong Le; Phuoc Dung Nguyen; Mai Anh Tran; The-Hung Bui; Thanh Van Ta; Van Khanh Tran
Journal:  Anemia       Date:  2022-07-05

3.  Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population.

Authors:  Nguyen Thi Hue; Jean Paul Charlieu; Tran Thi Hong Chau; Nick Day; Jeremy J Farrar; Tran Tinh Hien; Sarah J Dunstan
Journal:  Malar J       Date:  2009-07-10       Impact factor: 2.979

4.  An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.

Authors:  Neena Valecha; Aung Pyae Phyo; Mayfong Mayxay; Paul N Newton; Srivicha Krudsood; Sommay Keomany; Maniphone Khanthavong; Tiengkham Pongvongsa; Ronnatrai Ruangveerayuth; Chirapong Uthaisil; David Ubben; Stephan Duparc; Antonella Bacchieri; Marco Corsi; Bappanad H K Rao; Prabash C Bhattacharya; Nagesh Dubhashi; Susanta K Ghosh; Vas Dev; Ashwani Kumar; Sasithon Pukrittayakamee; Sasithon Pukittayakamee
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

5.  Is there a need for neonatal screening of glucose-6-phosphate dehydrogenase deficiency in Canada?

Authors:  Aaron Leong
Journal:  Mcgill J Med       Date:  2007-01

6.  Medical expenses of patients with Favism admitted to 17th Shahrivar Hospital compared to G6PD enzyme screening cost, in north of Iran.

Authors:  B Darbandi; M Noghbaei; F Mehrabian; M Jafroodi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-04-20

7.  Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax-endemic area in the Republic of Korea (ROK).

Authors:  Wonsig Lee; Sang-Eun Lee; Min Jun Lee; Kyung Tae Noh
Journal:  Malar J       Date:  2020-09-01       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.